Find A Research Study


Study Title: Novartis Fingolimod MS Study
Category: Neurology

Currently accepting participants?
Yes - please read the description below and contact the study coordinator if you are interested.

Principal Investigator: Mariko Kita
Study Coordinator: Leslie Stevens
Phone: 206-223-6835
Email: leslie.stevens@vmmc.org

What is the Novartis Fingolimod MS Study study?

This study is looking at an oral medication in the treatment of relapsing remitting Multiple Sclerosis.

Who can participate?

People ages 18-55, who have RRMS with at least 1
relapse within the calendar year or 2 relapses
within the past 2 years will be eligible. Patients
cannot be on any other medications for their RRMS
and must be healthy except for their diagnosis.

What do I have to do as a study participant?

If eligible, the patient would have to come to
Virginia Mason at least once a month for the first
6 months of the study. The screening process takes
at least 2 visits and requires a time commitment.
After the first 6 months visits will decrease to
once every 3 months. Each visit will contain lab
work. At various visits patients will have to
undergo a variety of tests such as an ECG, MRI,
PFT's, an eye exam and a skin exam. There will
also be specific tests done by the doctor to rate
their symptoms of RRMS.

Study Summary:

Detailed Study Description:

(No information)

Study Design:
Phase of Study:
Study Type:
Condition or Study Focus:
Intervention Type:
Intervention Name:
Gender:
Age group:
Sponsor:


Other studies in this category include:

Studies currently accepting study participants:

Studies currently not accepting study participants:

No studies currently listed. Please try another category.